Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Institute Of Process Engineering Chinese Academy Of Sciences holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 5 pending office actions, which are distributed among 5 distinct examiners. This distribution ensures that each of the 5 pending office actions is reviewed by a unique official, spreading the prosecution across several individuals. These examiners are located within 3 distinct art units, reflecting the various process engineering and biotechnological aspects of the institute's work.
LEONARD, ARTHUR S is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. Since there are 5 distinct examiners for the 5 pending office actions, each official is currently handling exactly one matter. The 3 distinct art units involved suggest that the 5 pending office actions fall into a few different technical categories. Practitioners should tailor their responses to the 5 distinct examiners while considering the specific requirements of the 3 art units to successfully manage the Institute Of Process Engineering Chinese Academy Of Sciences portfolio. This diverse examiner pool requires a coordinated approach to maintain consistency.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEONARD, ARTHUR S | 1 | 50.8% | +50.2% |
| KAHN, RACHEL | 1 | 27.9% | +17.4% |
| BAKSHI, PANCHAM | 1 | 76.8% | +30.2% |
| JEONG, YOUNGSUL | 1 | 71.5% | +21.6% |
| ROGERS, JAMES WILLIAM | 1 | 46.2% | +22.3% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18981653 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | LEONARD, ARTHUR S | 141d overdue |
| 17759251 | Sugar Chain and Compositions Thereof and Use Thereof in Prevention and/or Treatment of Coronavirus Infection | BERRY, LAYLA D | 21d |
| 18575118 | POLYCARBONATE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KAHN, RACHEL | — |
| 18548448 | HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF | BAKSHI, PANCHAM | — |
| 17924931 | Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof | ROGERS, JAMES WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18981653 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | LEONARD, ARTHUR S | 141d overdue |
| 15734067 | Method and Device for Extracting Clean Liquid from Slurry Reactor | JEONG, YOUNGSUL | 119d overdue |
| 18575118 | POLYCARBONATE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KAHN, RACHEL | — |
| 18548448 | HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF | BAKSHI, PANCHAM | — |
| 17924931 | Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof | ROGERS, JAMES WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| 1772 | 1 |
| 1618 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18981653 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | LEONARD, ARTHUR S | 1631 | §103§112 | Non-Final OA | 141d overdue | Pending | Dec 16, 2024 |
| 18575118 | POLYCARBONATE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KAHN, RACHEL | — | §103 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18548448 | HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF | BAKSHI, PANCHAM | — | §103§112 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 15734067 | Method and Device for Extracting Clean Liquid from Slurry Reactor | JEONG, YOUNGSUL | 1772 | §103 | Non-Final OA | 119d overdue | Pending | Mar 15, 2023 |
| 17924931 | Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof | ROGERS, JAMES WILLIAM | 1618 | §103§112 | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17759251 | Sugar Chain and Compositions Thereof and Use Thereof in Prevention and/or Treatment of Coronavirus Infection | BERRY, LAYLA D | 1693 | §101§102 | Final Rejection | 21d | Pending | Jul 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial